CDC Report: Obesity's Cancer Link a Major Concern for Alabama, One of Fattest States

Why it matters locally: The CDC's report linking obesity to rising cancer rates is particularly relevant and concerning for Alabama residents. With Alabama consistently ranking high in national obesity statistics, this news directly impacts the health and well-being of a significant portion of the state's population. The increased risk of obesity-related cancers, including breast, colon, and endometrial cancers, could strain Alabama's healthcare system, increase healthcare costs for individuals and the state, and potentially shorten life expectancies. Alabamians should take caution in their day to day diet, nutrition, and activity. Businesses in Alabama, especially those in the healthcare and wellness sectors, also need to pay close attention to these findings. Hospitals and clinics may need to expand their oncology services, while wellness programs and initiatives aimed at promoting healthy lifestyles could see increased demand. Furthermore, this report underscores the importance of ongoing public health campaigns and policy efforts aimed at addressing obesity rates in the state. The Alabama state government should take precautions and develop actionable plans. If obesity isn't curtailed, the state's healthcare will suffer tremendously.

---

Atlanta -- A Centers for Disease Control and Prevention (CDC) report released this week highlights the association between overweight and obesity and the incidence of certain types of cancer. The Vital Signs report indicates that while the overall cancer rate in the United States is decreasing, the proportion of cancers linked to excess weight is increasing. According to the CDC findings, cancers associated with overweight and obesity accounted for 40% of all cancers diagnosed in the U.S. in 2014. The report identifies at least 13 different types of cancer that have been linked to being overweight or obese. The data show a significant portion of these obesity-related cancers, approximately two-thirds, are diagnosed in adults between the ages of 50 and 74.